|
Canada-0-TileCeramicDistributors Company Direktoryo
|
Company News :
- FDAs Global Substance Registration System
FDA's Global Substance Registration System enables efficient and accurate exchange of information on substances through their Unique Ingredient Identifiers (UNIIs)
- Registration and Listing | FDA
Domestic and foreign establishments that manufacture, repack, or re-label drug products in the United States are required to register with the FDA Domestic and foreign drug manufacturers,
- National Institutes of Health - The GSRS project
The Global Substance Registration System (GSRS) enables efficient and accurate exchange of information on substances through their Unique Ingredient Identifiers (UNIIs) which can be generated at any time in the regulatory life cycle
- eCFR :: 21 CFR Part 207 -- Requirements for Foreign and Domestic . . .
For each drug being manufactured, repacked, relabeled, or salvaged for commercial distribution at an establishment at the time of initial registration, drug listing information must be submitted no later than 3 calendar days after the initial registration of the establishment
- Global Substance Registration System - GSRS
The primary goal of the Global Substance Registration System (GSRS) program is the production of software to assist agencies in registering and documenting information about substances found in medicines and other regulated products
- openFDA - Food and Drug Administration
The overall purpose of the joint FDA USP Substance Registration System (SRS) is to support health information technology initiatives by generating unique ingredient identifiers (UNIIs) for
- 21 CFR Part 1301 -- Registration of Manufacturers, Distributors, and . . .
§ 1301 12 Separate registrations for separate locations (a) A separate registration is required for each principal place of business or professional practice at one general physical location where controlled substances are manufactured, distributed, imported, exported, or dispensed by a person
- FDA Label Search
The drug labels and other drug-specific information on this Web site represent the most recent drug listing information companies have submitted to the Food and Drug Administration (FDA)
- Establishment Registration and Listing for Human Drugs
By approximately the end of 2018, FDA intends to purge drug registration and listing information submitted in the past on paper and not yet migrated to electronic submission
- FDA Dashboards - Home
The Data Dashboard contains data elements from FDA compliance and enforcement data sources, including Inspections, Compliance Actions, Recalls, Imports, and Food Safety Modernization Act programs New dashboards with additional sources will continue to be added Further information about specific data is available on the Compliance Dashboards or FSMA Data Search pages Questions and comments
|
|